<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04391634</url>
  </required_header>
  <id_info>
    <org_study_id>388/16</org_study_id>
    <nct_id>NCT04391634</nct_id>
  </id_info>
  <brief_title>Cerebral and Circulatory Effects of Neonatal Volume Targeted Ventilation</brief_title>
  <official_title>Cerebral Oxygenation and Circulatory Parameters During Pressure Controlled vs. Volume Targeted Mechanical Ventilation in the Extremely Preterm Infants With Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poznan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poznan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to assess the effect of volume targeted vs. pressure-controlled
      mechanical ventilation (MV) on circulatory parameters and cerebral oxygenation in the
      extremely preterm infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, cross-over trial enrolling neonates &lt;28 weeks' gestation requiring MV. Patients
      were ventilated for 3 hours with pressure controlled assist-control (PC-AC) mode, followed by
      3-hours of volume guarantee assist-control ventilation (VG-AC). Continuous monitoring was
      carried out using pulse oximetry (oxygen saturation - SpO2 and heart rate - HR),
      near-infrared spectroscopy (cerebral oxygenation - StO2) and electrical cardiometry
      (circulatory parameters).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">May 30, 2018</completion_date>
  <primary_completion_date type="Actual">May 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>prospective crossover study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>StO2</measure>
    <time_frame>6 hours</time_frame>
    <description>Cerebral oxygenation measured using near-infrared spectroscopy [percent]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke volume</measure>
    <time_frame>6 hours</time_frame>
    <description>Stroke volume (SV) monitored with electrical cardiometry [ml]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>6 hours</time_frame>
    <description>Cardiac output (CO) monitored with electrical cardiometry [L/min]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke index</measure>
    <time_frame>6 hours</time_frame>
    <description>Stroke index (SI) monitored with electrical cardiometry [ml/m2]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac index</measure>
    <time_frame>6 hours</time_frame>
    <description>Cardiac index (CI) monitored with electrical cardiometry [L/min/m2]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke volume variation (SVV)</measure>
    <time_frame>6 hours</time_frame>
    <description>Stroke volume variation (SVV) monitored with electrical cardiometry [percent]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Index of contractility</measure>
    <time_frame>6 hours</time_frame>
    <description>Index of contractility (ICON) monitored with electrical cardiometry</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <condition>Respiratory Failure</condition>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>Mechanical ventilation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Preterm infants on mechanical ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>volume guarantee</intervention_name>
    <description>volume guarantee assist-control mechanical ventilation</description>
    <arm_group_label>Mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pressure-controlled</intervention_name>
    <description>pressure-controlled assist-control mechanical ventilation</description>
    <arm_group_label>Mechanical ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  premature infants born &lt;28 weeks of gestation

          -  respiratory failure in the course of respiratory distress syndrome requiring
             mechanical ventilation

          -  stable condition with pH (acidity of blood)&gt; 7.2 and pCO2 (carbon dioxide partial
             pressure) &lt;60 mmHg in the blood gas analysis

          -  no identified genetic syndromes and serious congenital malformations

        Exclusion Criteria:

          -  lack of written consent of patients' parents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Weeks</minimum_age>
    <maximum_age>27 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomasz Szczapa, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Poznan University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neonatology at Poznań University of Medical Sciences</name>
      <address>
        <city>Poznań</city>
        <zip>60-535</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>May 19, 2020</last_update_submitted>
  <last_update_submitted_qc>May 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

